Literature DB >> 18754318

Dendritic cell infiltration pattern along the colorectal adenoma-carcinoma sequence.

Aping Yuan1, Sonja E Steigen, Rasmus Goll, Barthold Vonen, Anne Husbekk, Guanglin Cui, Jon Florholmen.   

Abstract

We have previously reported that the dendritic cell (DC) functional index cytokine interleukin-12 was significantly decreased in colorectal carcinoma (CRC) tissues. In this study, the DC infiltration pattern and the density of mature DCs (mDCs; labeled by anti-CD83 and anti-CD208) and immature DCs (iDCs; labeled by anti-CD1alpha) were characterized using immunohistochemistry (IHC) in tissue samples from 23 patients with CRC, 33 patients with colorectal adenoma (CRA), and 19 healthy controls. In addition, the DC function inhibitor cyclooxygenase-2 (COX-2) and the downstream signal molecule prostaglandin E2 (PGE2) and related receptors EP2/EP4 were measured by quantitative real-time PCR and double immunofluorescence staining. The IHC analyses revealed changed densities of mDCs and iDCs in the tumor microenvironment; in CRA and CRC, the density of mDCs was decreased, but the density of iDCs was gradually increased. Furthermore, the distribution patterns of DCs were also altered. In CRA, mDCs were abundantly distributed in the subepithelial stroma of the adenomatous mass. In CRC, the distribution of mDCs in the tumor stroma was not homogeneous, and mDCs residing in the stroma at invading edges were more frequently found compared with in the intratumoral stroma (P<0.05). Increased iDCs were found in the intratumoral mass in CRC, and some infiltrated into the malignant epithelium. By quantitative real-time PCR, a gradually increased level of COX-2 mRNA was demonstrated in the local tissues along the adenoma-carcinoma sequence, and double immunofluorescence staining showed a colocalization of PGE2 receptors EP2/EP4 with mDCs in the stroma of CRC. In conclusion, our current findings revealed an altered DC infiltration pattern along the adenoma-carcinoma sequence; gradually increased COX-2 expression might contribute to the DC functional defect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754318

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  23 in total

1.  Quantification of blood dendritic cells in colorectal cancer patients during the course of disease.

Authors:  Giulia Orsini; Annalisa Legitimo; Alessandra Failli; Paola Ferrari; Andrea Nicolini; Roberto Spisni; Paolo Miccoli; Rita Consolini
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

2.  Role of dendritic cells in progression and clinical outcome of colon cancer.

Authors:  Maya V Gulubova; Julian R Ananiev; Tatyana I Vlaykova; Yovcho Yovchev; Vanya Tsoneva; Irena M Manolova
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Hang Yang; Jianbo Zhao; Aping Yuan; Jon Florholmen
Journal:  Pathol Oncol Res       Date:  2014-05-25       Impact factor: 3.201

4.  Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers.

Authors:  Guanglin Cui; Can Li; Gang Xu; Zhenglu Sun; Li Zhu; Zhengfen Li; Wei Zheng; Junling Li; Aping Yuan
Journal:  Pathol Oncol Res       Date:  2017-05-03       Impact factor: 3.201

5.  Body composition of the host influences dendritic cell phenotype in patients treated for colorectal cancer.

Authors:  George Malietzis; Gui Han Lee; Hafid O Al-Hassi; David Bernardo; Alexandra I F Blakemore; Robin H Kennedy; Morgan Moorghen; John T Jenkins; Stella C Knight
Journal:  Tumour Biol       Date:  2016-03-10

Review 6.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

7.  Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.

Authors:  Timothy J Zumwalt; Ajay Goel
Journal:  Curr Colorectal Cancer Rep       Date:  2015-06-29

8.  Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans.

Authors:  Kristin Wallace; Georges J Nahhas; Christine Bookhout; David N Lewin; Chrystal M Paulos; Nana Nikolaishvili-Feinberg; Stephanie M Cohen; Silvia Guglietta; Ali Bakhtiari; E Ramsay Camp; Elizabeth G Hill; John A Baron; Jennifer D Wu; Alexander V Alekseyenko
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

9.  Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.

Authors:  Kristin Wallace; Georges J El Nahas; Christine Bookhout; Jessica E Thaxton; David N Lewin; Nana Nikolaishvili-Feinberg; Stephanie M Cohen; J Grant Brazeal; Elizabeth G Hill; Jennifer D Wu; John A Baron; Alexander V Alekseyenko
Journal:  Cancer Prev Res (Phila)       Date:  2021-08-02

Review 10.  Colorectal cancer prevention: Immune modulation taking the stage.

Authors:  Rochelle Fletcher; Yi-Jun Wang; Robert E Schoen; Olivera J Finn; Jian Yu; Lin Zhang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 11.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.